Collectively, the lower IL-6 levels associated with higher PGE2 and TNFRSF1a levels suggest that non-PASC patients may present a diminished inflammatory response instead of increased classical cytokines related to low-grade inflammation. Here, TNFRSF1A is linked to long COVID-19.